Literature DB >> 17364638

Compulsive activity and anterograde amnesia after zolpidem use.

Ming-Jun Tsai1, Yi-Hung Tsai, Yaw-Bin Huang.   

Abstract

BACKGROUND: Zolpidem is a selective GABAAalpha1 receptor modulator used for its hypnotic-sedative properties. Zolpidem has side effects that are similar but not identical to the benzodiazepines. We report the first cases of compulsive activity combined with anterograde amnesia after the use of zolpidem. CASE REPORT: Three women experienced anterograde amnesia and compulsive repetitive behaviors after zolpidem use. These activities consisted of cleaning, shopping, and eating. These behaviors stopped after discontinuation of the zolpidem.
CONCLUSION: These reports demonstrate that compulsive activity combined with anterograde amnesia may be associated with the use of zolpidem. Physicians and pharmacists should be aware of this potential side effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17364638     DOI: 10.1080/15563650600956741

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  13 in total

1.  Darwin's Predisposition and the Restlessness that Drives Sleepwalking.

Authors:  Michael Howell
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

2.  Adverse reactions to zolpidem: case reports and a review of the literature.

Authors:  Takuji Inagaki; Tsuyoshi Miyaoka; Seiichi Tsuji; Yasushi Inami; Akira Nishida; Jun Horiguchi
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  Sleep self-intoxication and sleep driving as rare zolpidem-induced complex behaviour.

Authors:  Alexander Paulke; Cora Wunder; Stefan W Toennes
Journal:  Int J Legal Med       Date:  2014-04-27       Impact factor: 2.686

Review 4.  Hypnosedative-induced complex behaviours : incidence, mechanisms and management.

Authors:  Christian R Dolder; Michael H Nelson
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 5.  In the Zzz zone: the effects of Z-drugs on human performance and driving.

Authors:  Naren Gunja
Journal:  J Med Toxicol       Date:  2013-06

Review 6.  Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.

Authors:  Romy Hoque; Andrew L Chesson
Journal:  J Clin Sleep Med       Date:  2009-10-15       Impact factor: 4.062

Review 7.  Parasomnias: an updated review.

Authors:  Michael J Howell
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

8.  A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T.

Authors:  Stephanie C Licata; J Eric Jensen; David M Penetar; Andrew P Prescot; Scott E Lukas; Perry F Renshaw
Journal:  Psychopharmacology (Berl)       Date:  2009-01-06       Impact factor: 4.530

Review 9.  Comparative tolerability of newer agents for insomnia.

Authors:  Gary Zammit
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Treatment of nocturnal eating disorders.

Authors:  Michael J Howell; Carlos H Schenck
Journal:  Curr Treat Options Neurol       Date:  2009-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.